Skip to content

Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care

Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02558998
Enrollment
120
Registered
2015-09-24
Start date
2015-03-31
Completion date
2019-03-31
Last updated
2020-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Small Cell Lung Carcinoma (NSCLC)

Brief summary

The objective of this study is to 1) evaluate the impact of a novel individualized care planning/ educational technology (the On Q Care Planning System or CPS) on oncology patient and provider knowledge, attitudes and beliefs about Non-Small Cell Lung Carcinoma (NSCLC) clinical trials, as well as 2) to evaluate the impact of the On Q CPS on patient referral to and enrollment in NSCLC clinical trials.

Interventions

OTHERSurvey

Sponsors

Abramson Cancer Center at Penn Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All participants must be 18 years of age or older. * Patient participants must have Stage III, IV and/or recurrent NSCLC. * Patient participants must be at a point of treatment initiation/change or evaluation for treatment initiation/change * Patients must have working email address and internet access

Exclusion criteria

* Any participant who cannot understand written or spoken English. * Any participant who is not competent to provide informed consent for study participation per the investigator. * Any participant who cannot be present for the related study visits and/or complete the post-test assessment

Design outcomes

Primary

MeasureTime frame
Number of patient who completed surveys8 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026